
Razelle Kurzrock, MD, FACP
Center Associate Director, Professor
Locations
- Froedtert Hospital
- Clinical Cancer Center - Froedtert Hospital
Specialties
- Medical Oncology
Languages
- English
Clinical Cancer Center - Froedtert Hospital
Education
- MD - Doctor of Medicine
- FACP - Fellow of the American College of Physicians
Leadership Positions
- Associate Director of Clinical Research, Cancer Center
- Associate Director of Clinical Research, GSPMC
Publications
-
Critical evaluation of the ProfiLER-02 study design and outcomes.
(Subbiah V, Kurzrock R.) Nat Med. 2025 Sep 10 PMID: 40931035 SCOPUS ID: 2-s2.0-105016134568 09/11/2025
-
Ag(e)nostic precision oncology therapy approvals across the years.
(Kudek MR, Adashek JJ, Kurzrock R.) Trends Cancer. 2025 Aug;11(8):726-735 PMID: 40480903 PMCID: PMC12350067 SCOPUS ID: 2-s2.0-105007440053 06/07/2025
-
(Chae YK, Othus M, Patel SP, Aljumaily R, Win KZ, Pejovic T, Thomas SS, Robinson WR 3rd, Kim HS, Chung LI, McLeod CM, Chen HX, Sharon E, Streicher H, Ryan CW, Blanke CD, Kurzrock R.) Cancer Commun (Lond). 2025 Aug;45(8):976-986 PMID: 40402690 PMCID: PMC12365539 SCOPUS ID: 2-s2.0-105006448395 05/22/2025
-
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial.
(Meric-Bernstam F, Raghav KPS, Sweeney CJ, Swanton C, Spigel DR, Bose R, Burris HA, Friedman CF, Espenschied CR, Grindheim JM, Malato J, Schulze K, Price R, Kurzrock R.) Clin Cancer Res. 2025 Jul 15;31(14):2935-2944 PMID: 40512191 PMCID: PMC7618057 SCOPUS ID: 2-s2.0-105011600837 06/13/2025
-
Personalized N-of-1 Combination Therapies for Advanced Gastrointestinal Stromal Tumors.
(Noh S, Sharma AK, Fanta PT, Kato S, Kurzrock R, Sicklick JK.) JCO Precis Oncol. 2025 Jul;9:e2500066 PMID: 40700673 PMCID: PMC12313172 SCOPUS ID: 2-s2.0-105011966716 07/23/2025
-
(Patel SP, Fisher J, Chae YK, Soto LS, Kasi A, Konda B, Walshauser M, Parra E, Zhang J, Duault C, Gonzalez-Kozlova E, Manyam G, Zhang J, Chen H, Duose DY, Laberiano Fernandez C, Luthra R, Al-Atrash G, Kim-Schulze S, Maecker HT, Wistuba II, Gnjatic S, Lee JJ, Zhang J, Magner CM, Chen HX, Sharon E, Othus M, Ryan CW, Blanke C, Haymaker CL, Kurzrock R.) J Immunother Cancer. 2025 Jun 30;13(6) PMID: 40588371 PMCID: PMC12211841 SCOPUS ID: 2-s2.0-105009645105 07/01/2025
-
(Swanton C, Madison RW, Tambaoan CFB, Meric-Bernstam F, Sweeney CJ, Kurzrock R, Burris HA 3rd, Spigel DR, Tukachinsky H, Hughes J, Malato J, Yoo B, Szado T, Schwab C, Pasquina LW, Gasco A, Schulze K, Friedman CF.) Mol Oncol. 2025 May 28 PMID: 40434907 SCOPUS ID: 2-s2.0-105006911407 05/28/2025
-
Cancer treatment paradigms in the precision medicine era.
(Subbiah V, Curigliano G, Sicklick JK, Kato S, Tasken K, Medford A, Rieke DT, Chen HZ, Wahida A, Buschhorn L, Horgan D, Kurzrock R.) Nat Med. 2025 May 20 PMID: 40394190 SCOPUS ID: 2-s2.0-105005797459 05/21/2025
-
Toll-like receptor 3: a double-edged sword
(Hsieh ML, Nishizaki D, Adashek JJ, Kato S, Kurzrock R.) Biomarker Research. December 2025;13(1) SCOPUS ID: 2-s2.0-85218427562 12/01/2025
-
OncoAID: an open access targeted anti-cancer drugs database.
(Landau O, Magidi S, Bresson C, Wunder F, Kurzrock R, El-Deiry WS, Thangathurai K, Rubin E.) Front Pharmacol. 2025;16:1588191 PMID: 40880638 PMCID: PMC12380929 SCOPUS ID: 2-s2.0-105014910954 08/31/2025
-
(Gianchandani A, Desai D, Sambath J, Patil D, Kumar P, Singh S, Madre C, Deshpande R, Parab A, Shah N, Shah D, Kataria P, Atluri S, Mehta M, Shreenivas A, Datar R, Kurzrock R, Limaye S.) Journal of Immunotherapy and Precision Oncology. August 2025;8(3):206-211 SCOPUS ID: 2-s2.0-105014966943 08/01/2025
-
Tumour-agnostic kinase inhibitors
(Adashek JJ, Nikanjam M, Kurzrock R.) Nature Reviews Drug Discovery. July 2025;24(7):504-520 SCOPUS ID: 2-s2.0-86000326760 07/01/2025